---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-033824"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2022-11-28T23:59:59+00:00"
generated_at: "2026-06-21T12:40:34.321086+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience receives Nasdaq delisting notice for low stockholders' equity

## Summary
- Stockholders' equity of $1,287,224 as of Sept 30, 2022, below Nasdaq's $2.5M minimum requirement.
- Must submit a compliance plan to Nasdaq by January 7, 2023 (45 days from November 23, 2022).
- If plan accepted, Nasdaq may grant up to 180-day extension to regain compliance.
- Failure to regain compliance could result in delisting, with right to appeal to Nasdaq Hearings Panel.

## SEC filing metadata
- accession: 0001493152-22-033824
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2022-11-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315222033824/0001493152-22-033824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315222033824/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-033824
- JSON: https://secwatch.observer/filing/0001493152-22-033824.json
- Plain text: https://secwatch.observer/filing/0001493152-22-033824.txt

## Key facts
- Listing & Compliance Notices
  INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: (the “Stockholders’ Equity Requirement). In the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, the Company reported stockholders’ equity of $1,287,224, which is below the Stockholders’ Equity Requirement for continued listing. Additionally, as of the date of the Notice, the Company did not meet either of the alternative Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315222033824/0001493152-22-033824-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.